Arctic Bioscience (Norway) Analysis
ABS Stock | NOK 1.94 0.05 2.51% |
Arctic Bioscience AS is overvalued with Real Value of 1.91 and Hype Value of 1.99. The main objective of Arctic Bioscience stock analysis is to determine its intrinsic value, which is an estimate of what Arctic Bioscience AS is worth, separate from its market price. There are two main types of Arctic Bioscience's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Arctic Bioscience's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Arctic Bioscience's stock to identify patterns and trends that may indicate its future price movements.
The Arctic Bioscience stock is traded in Norway on Oslo Stock Exchange, with the market opening at 09:00:00 and closing at 16:20:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Norway.
Arctic |
Arctic Stock Analysis Notes
About 55.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.05. Some equities with similar Price to Book (P/B) outperform the market in the long run. Arctic Bioscience recorded a loss per share of 1.75. The entity had not issued any dividends in recent years. Arctic Bioscience AS, a biotechnology company, provides nutraceutical and pharmaceutical products. Arctic Bioscience AS was incorporated in 2011 and is based in rsta, Norway. ARCTIC BIOSCIENCE is traded on Oslo Stock Exchange in Norway. For more info on Arctic Bioscience AS please contact the company at 47 95 29 33 84 or go to https://www.arctic-bioscience.com.Arctic Bioscience Investment Alerts
Arctic Bioscience generated a negative expected return over the last 90 days | |
Arctic Bioscience has high historical volatility and very poor performance | |
Arctic Bioscience may become a speculative penny stock | |
Arctic Bioscience has high likelihood to experience some financial distress in the next 2 years | |
The company reported the revenue of 21.52 M. Net Loss for the year was (42.58 M) with profit before overhead, payroll, taxes, and interest of 5.8 M. | |
Arctic Bioscience generates negative cash flow from operations | |
About 55.0% of the company shares are held by company insiders |
Arctic Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 276.66 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Arctic Bioscience's market, we take the total number of its shares issued and multiply it by Arctic Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Arctic Profitablity
Arctic Bioscience's profitability indicators refer to fundamental financial ratios that showcase Arctic Bioscience's ability to generate income relative to its revenue or operating costs. If, let's say, Arctic Bioscience is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Arctic Bioscience's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Arctic Bioscience's profitability requires more research than a typical breakdown of Arctic Bioscience's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.98) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.86) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.86. Technical Drivers
As of the 2nd of December, Arctic Bioscience shows the mean deviation of 7.45, and Risk Adjusted Performance of (0.06). Arctic Bioscience technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Arctic Bioscience information ratio, and the relationship between the coefficient of variation and value at risk to decide if Arctic Bioscience is priced correctly, providing market reflects its regular price of 1.94 per share.Arctic Bioscience Price Movement Analysis
The output start index for this execution was twenty-seven with a total number of output elements of thirty-four. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Arctic Bioscience middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Arctic Bioscience. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Arctic Bioscience Predictive Daily Indicators
Arctic Bioscience intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Arctic Bioscience stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 3051.84 | |||
Daily Balance Of Power | (0.26) | |||
Rate Of Daily Change | 0.97 | |||
Day Median Price | 1.9 | |||
Day Typical Price | 1.91 | |||
Price Action Indicator | 0.02 | |||
Period Momentum Indicator | (0.05) |
Arctic Bioscience Forecast Models
Arctic Bioscience's time-series forecasting models are one of many Arctic Bioscience's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Arctic Bioscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Arctic Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Arctic Bioscience prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Arctic shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Arctic Bioscience. By using and applying Arctic Stock analysis, traders can create a robust methodology for identifying Arctic entry and exit points for their positions.
Arctic Bioscience AS, a biotechnology company, provides nutraceutical and pharmaceutical products. Arctic Bioscience AS was incorporated in 2011 and is based in rsta, Norway. ARCTIC BIOSCIENCE is traded on Oslo Stock Exchange in Norway.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Arctic Bioscience to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
All Next | Launch Module |
Other Information on Investing in Arctic Stock
Arctic Bioscience financial ratios help investors to determine whether Arctic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arctic with respect to the benefits of owning Arctic Bioscience security.